Healthcare provider profile · identity verified

Matthew Gunn Weeks, M.D.

Family Practice · NORTH OGDEN, UT · NPI 1053346734

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	436	139
Levothyroxine Sodium	Levothyroxine Sodium	340	104
Losartan Potassium	Losartan Potassium	320	96
Omeprazole	Omeprazole	316	94
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	311	42
Zolpidem Tartrate	Zolpidem Tartrate	308	44
Alprazolam	Alprazolam	249	42
Gabapentin	Gabapentin	249	55
Amlodipine Besylate	Amlodipine Besylate	247	76
Rosuvastatin Calcium	Rosuvastatin Calcium	223	73
Lisinopril	Lisinopril	206	63
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	196	23
Potassium Chloride	Potassium Chloride	174	50
Metoprolol Succinate	Metoprolol Succinate	169	55
Trazodone Hcl	Trazodone Hcl	169	45
Pravastatin Sodium	Pravastatin Sodium	160	43
Metformin Hcl Er	Metformin Hcl	149	44
Metformin Hcl	Metformin Hcl	145	43
Tamsulosin Hcl	Tamsulosin Hcl	145	52
Fluticasone Propionate	Fluticasone Propionate	141	41
Albuterol Sulfate Hfa	Albuterol Sulfate	133	61
Pantoprazole Sodium	Pantoprazole Sodium	130	37
Duloxetine Hcl	Duloxetine Hcl	127	36
Meloxicam	Meloxicam	118	47
Escitalopram Oxalate	Escitalopram Oxalate	116	36
Celecoxib	Celecoxib	111	38
Alendronate Sodium	Alendronate Sodium	102	27
Oxycodone Hcl	Oxycodone Hcl	102	12
Famotidine	Famotidine	101	26
Furosemide	Furosemide	100	33
Prednisone	Prednisone	100	55
Finasteride	Finasteride	99	30
Simvastatin	Simvastatin	96	24
Lorazepam	Lorazepam	94	17
Fluoxetine Hcl	Fluoxetine Hcl	90	28
Eliquis	Apixaban	88	24
Jardiance	Empagliflozin	87	20
Tramadol Hcl	Tramadol Hcl	85	21
Hydrochlorothiazide	Hydrochlorothiazide	82	30
Trulicity	Dulaglutide	82	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	80	14
Pregabalin	Pregabalin	80	17
Ozempic	Semaglutide	79	16
Buprenorphine Hcl	Buprenorphine Hcl	74	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	71	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	19
Sertraline Hcl	Sertraline Hcl	69	21
Tizanidine Hcl	Tizanidine Hcl	63	16
Montelukast Sodium	Montelukast Sodium	61	19
Clonazepam	Clonazepam	59	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	59	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	18
Mounjaro	Tirzepatide	57	suppressed
Allopurinol	Allopurinol	55	20
Carvedilol	Carvedilol	55	20
Diazepam	Diazepam	55	12
Promethazine Hcl	Promethazine Hcl	53	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	50	17
Xarelto	Rivaroxaban	49	11
Methocarbamol	Methocarbamol	43	suppressed
Bupropion Xl	Bupropion Hcl	42	14
Estradiol	Estradiol	42	14
Glimepiride	Glimepiride	41	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Amoxicillin	Amoxicillin	38	26
Doxycycline Monohydrate	Doxycycline Monohydrate	38	24
Propranolol Hcl	Propranolol Hcl	38	15
Ropinirole Hcl	Ropinirole Hcl	38	12
Ondansetron Odt	Ondansetron	36	15
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	20
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Ibuprofen	Ibuprofen	31	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	14
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Cephalexin	Cephalexin	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	29	suppressed
Loperamide	Loperamide Hcl	29	suppressed
Azithromycin	Azithromycin	28	18
Linzess	Linaclotide	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	26	suppressed
Topiramate	Topiramate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	12
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fluconazole	Fluconazole	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Modafinil	Modafinil	19	suppressed
Penicillin V Potassium	Penicillin V Potassium	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Baclofen	Baclofen	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Movantik	Naloxegol Oxalate	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Mupirocin	Mupirocin	14	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Triazolam	Triazolam	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Effexor Xr	Venlafaxine Hcl	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Testosterone	Testosterone	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error